Demography	Cholesterol	Blood pressure	Risk factors
Age: 65	Total: 170	Systolic: 115	Diabetes: no
Gender: male	HDL: 70	Diastolic: 75	Smoking: no
Race: not African-American		On medication: no

Notes and further reading

• Moderate intensity statin may be atorvastatin 10mg, pravastatin 40mg, or simvastatin 20-40mg. High intensity statin may be atorvastatin 40mg-80mg.
• AHA/ACC guidelines stress the importance of lifestyle modifications to lower cardiovascular disease risk in all patients. This includes eating a heart-healthy diet, regular aerobic exercises, maintenance of desirable body weight and avoidance of tobacco products.
• Before initiating statin therapy, clinicians and patients ought to engage in a discussion which considers addressing risk factors such as smoking and optimal lifestyle, the potential for ASCVD risk reduction benefits, adverse medication effects, drug-drug interactions, and patient preferences for treatment.
• Additional factors may be considered to inform treatment decision making. These factors may include primary LDL-C greater than 160 mg/dL or other evidence of genetic hyperlipidemias, family history of premature ASCVD with onset less than 55 years of age in a first degree male relative or less than 65 years of age in a first degree female relative, high-sensitivity C-reactive protein greater than 2 mg/L, CAC score greater than 300 Agatston units or greater than 75 percentile for age, sex, and ethnicity, ankle-brachial index less than 0.9, or elevated lifetime risk of ASCVD.